Cargando…
Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis
BACKGROUND/OBJECTIVE: Coronavirus disease 2019 (COVID-19) is thought to contribute to diabetic ketoacidosis (DKA) and worse outcomes in patients with diabetes. This study compared the cumulative insulin dose required to achieve DKA resolution in the intensive care unit among patients with type 2 dia...
Autores principales: | Farzadfar, Daniela, Gordon, Caitlyn A., Falsetta, Keith P., Calder, Tori, Tsegaye, Adey, Kohn, Nina, Schulman-Rosenbaum, Rifka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AACE. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128332/ https://www.ncbi.nlm.nih.gov/pubmed/35623591 http://dx.doi.org/10.1016/j.eprac.2022.05.006 |
Ejemplares similares
-
Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
por: Gordon, Caitlyn, et al.
Publicado: (2023) -
Abstract #1153925: Dexamethasone Use and Insulin Requirements in Coronavirus Disease-19 (COVID-19) Infection
por: Barsoum, Barbara, et al.
Publicado: (2022) -
Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
por: Kinney, Justin, et al.
Publicado: (2021) -
Evaluation of Insulin Infusion Rates for the Treatment of Diabetic Ketoacidosis in the Emergency Department
por: Bass, Megan E., et al.
Publicado: (2022) -
Abstract #1406325: The Complexities of Managing Hypertriglyceridemia-Induced Pancreatitis in a Critically-Ill COVID-19 Patient
por: Schulman-Rosenbaum, Rifka
Publicado: (2023)